about
Multiple Infectious Agents and the Origins of Atherosclerotic Coronary Artery DiseaseCytomegalovirus and HIV: A Dangerous Pas de DeuxAntagonistic determinants controlling replicative and latent states of human cytomegalovirus infectionHigh prevalence of human cytomegalovirus in carotid atherosclerotic plaques obtained from Russian patients undergoing carotid endarterectomyComplex expression of the UL136 gene of human cytomegalovirus results in multiple protein isoforms with unique roles in replication.Human cytomegalovirus infection is associated with essential hypertension in Kazakh and Han Chinese populations.Persistent infection of human fetal endothelial cells with rubella virus.Human Cytomegalovirus UL135 and UL136 Genes Are Required for Postentry Tropism in Endothelial Cells.Murine Norovirus Infection Variably Alters Atherosclerosis in Mice Lacking Apolipoprotein EHuman cytomegalovirus glycoprotein complex gH/gL/gO uses PDGFR-α as a key for entry.Neovascularization of coronary tunica intima (DIT) is the cause of coronary atherosclerosis. Lipoproteins invade coronary intima via neovascularization from adventitial vasa vasorum, but not from the arterial lumen: a hypothesis.Gender differences and age-specific associations between body mass index and other cardiovascular risk factors in CMV infected and uninfected people.An endothelial cell-specific requirement for the UL133-UL138 locus of human cytomegalovirus for efficient virus maturationTransient activation of human cytomegalovirus lytic gene expression during latency allows cytotoxic T cell killing of latently infected cells.A novel cytomegalovirus-induced regulatory-type T-cell subset increases in size during older life and links virus-specific immunity to vascular pathology.Periodontal bacterial invasion and infection: contribution to atherosclerotic pathology.Cytomegalovirus Infection and Relative Risk of Cardiovascular Disease (Ischemic Heart Disease, Stroke, and Cardiovascular Death): A Meta-Analysis of Prospective Studies Up to 2016.Expanding role of cytomegalovirus as a human pathogen.The HCMV US28 vGPCR induces potent Gαq/PLC-β signaling in monocytes leading to increased adhesion to endothelial cells.Human cytomegalovirus may promote tumour progression by upregulating arginase-2.The Cell Biology of Cytomegalovirus: Implications for Transplantation.High anti-human cytomegalovirus antibody levels are associated with the progression of essential hypertension and target organ damage in Han Chinese population.ACSS2-mediated acetyl-CoA synthesis from acetate is necessary for human cytomegalovirus infectionHuman Cytomegalovirus Up-Regulates Endothelin Receptor Type B: Implication for Vasculopathies?Human cytomegalovirus induces upregulation of arginase II: possible implications for vasculopathies.Research on the human virome: where are we and what is next.Human cytomegalovirus-encoded miR-UL112 contributes to HCMV-mediated vascular diseases by inducing vascular endothelial cell dysfunction.Human cytomegalovirus infection and coronary heart disease: a systematic review.Human cytomegalovirus epidemiology and relationship to tuberculosis and cardiovascular disease risk factors in a rural Ugandan cohort.Periodontal bacterial invasion and infection: contribution to atherosclerotic pathology.Mussel-inspired post-heparinization of a stretchable hollow hydrogel tube and its potential application as an artificial blood vesselSwitching biological functionalities of biointerfaces via dynamic covalent bondsHuman Cytomegalovirus Latency: Targeting Differences in the Latently Infected Cell with a View to Clearing Latent Infection
P2860
Q27330093-F4F74A05-5E46-4E45-ABCE-5687B978C988Q30245376-44474A0C-EC37-4FA0-99FC-1F98D1BC4E7BQ33887823-7A21D4E7-9ABD-404C-839E-7750E7BB6589Q34253980-D9BDD6B5-4431-4EA6-9EE1-2A61FED7C2A0Q34594796-4591F393-1B02-4BA9-BDEE-7ED06D31F83FQ34669797-944DEDAC-5D93-4CA8-B7ED-D3C313E2B66AQ34938539-08A6AC7D-342F-4A13-A164-BEEBC51753A2Q35745418-362DC9EF-9EE8-414D-89F5-CC9C21443DC2Q36197571-6575DCEC-9932-4751-B78B-9102C83E00EFQ36344878-157B0733-5AE1-432A-ADFC-7BE307190E13Q36380348-21A95123-498E-4FA4-9CCE-3E41AF2F0D74Q36475957-F3CD5A25-560D-428A-BF5F-1851293049F3Q36667906-5EE5D4E1-5C54-46CD-AF3A-CD8D301006A8Q36810228-C3D2156C-4CC9-4279-968D-6DBB9F377C27Q37696591-7EEDD868-C7CC-4C4C-8C75-8BC7ADBB0C50Q38102720-93AF6204-D1D0-4898-AF9F-DAC5A8D2C0B6Q38661693-D9FCAF9A-AD5F-407D-9603-E392E1C2D792Q38673038-75BA1786-E287-4742-BEC6-575E19801B9EQ38753492-CEC99EB8-1E08-42DB-B259-794F4F287D08Q38760685-A2CAB7BE-8A3B-4BD4-BFA0-3B0B83DF55BAQ38779938-CF6C4AF9-A701-4A9C-8EFC-15905FF7BF42Q40081161-DC6354F2-02EA-4201-82E0-DC7AA1582E15Q40342548-5695C5C7-4BAB-4D01-A67B-C3B1DECF79BEQ40849299-5C0DCAB8-DA00-4F30-96BA-064BE97C8693Q42242369-894F5219-BE02-46D9-936A-78DF30DD3F6BQ42543729-600F6F74-F870-46C9-AA99-125762A7070BQ47554093-6A8D8FD3-9BC7-4918-A685-E0BFFA132B0FQ48096321-A956160F-28D0-4D87-A435-EFD17D39EAACQ48097810-B89BB282-68F5-40EE-8900-ABEA5E41DA06Q53738748-E203A855-936B-45A8-BD1F-8B9CADFE5191Q57627805-E9A64171-A31B-44D9-A868-0D67764C5FA3Q57627836-34BDCE68-373E-4973-B002-4E53D3125CFEQ59072631-459988D0-86EC-41D0-8943-B8DC4F162ECC
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Human cytomegalovirus infection and atherothrombosis.
@en
Human cytomegalovirus infection and atherothrombosis.
@nl
type
label
Human cytomegalovirus infection and atherothrombosis.
@en
Human cytomegalovirus infection and atherothrombosis.
@nl
prefLabel
Human cytomegalovirus infection and atherothrombosis.
@en
Human cytomegalovirus infection and atherothrombosis.
@nl
P2093
P2860
P1476
Human cytomegalovirus infection and atherothrombosis.
@en
P2093
Branislava Dobutović
Esma R Isenović
Katarina Smiljanić
Milan Popović
Tatiana Syrovets
Thomas Simmet
P2860
P2888
P304
P356
10.1007/S11239-011-0662-X
P577
2012-02-01T00:00:00Z